Craig Gilgallon
Oprichter bij Cingulate Works, Inc.
Vermogen: 6 829 $ op 31-05-2024
Profiel
Craig Steven Gilgallon is the founder of Cingulate Works, Inc. (founded in 2013) and Cingulate, Inc. (founded in 2013).
He held the titles of Secretary, Executive VP & General Counsel at both companies.
Mr. Gilgallon is also the founder of Cingulate Therapeutics LLC.
Mr. Gilgallon's current job is as a Partner at Pawar Gilgallon & Rudy LLC (since 2012).
Mr. Gilgallon's education history includes an undergraduate degree from Ithaca College and a graduate degree from Thomas Jefferson School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CINGULATE, INC.
0.16% | 15-04-2024 | 9 742 ( 0.16% ) | 6 829 $ | 31-05-2024 |
Actieve functies van Craig Gilgallon
| Bedrijven | Functie | Begin |
|---|---|---|
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Oprichter | 01-01-2013 |
| Pawar Gilgallon & Rudy LLC | Corporate Officer/Principal | 01-01-2012 |
Eerdere bekende functies van Craig Gilgallon
| Bedrijven | Functie | Einde |
|---|---|---|
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Oprichter | 15-12-2023 |
| CINGULATE INC. | Oprichter | 15-12-2023 |
Opleiding van Craig Gilgallon
| Thomas Jefferson School of Law | Graduate Degree |
| Ithaca College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Pawar Gilgallon & Rudy LLC |
